DIVISLAB

Divi's Laboratories Limited

Pharmaceuticals

A leading manufacturer and exporter of active pharmaceutical ingredients, intermediates, and nutraceutical ingredients serving global pharmaceutical and healthcare markets. Incorporated in 1990, the company operates across multiple therapeutic segments with vertically integrated manufacturing infrastructure. It distinguishes itself through expertise in complex chemistry, stringent quality standards, and a diversified product portfolio catering to customers worldwide.

Investors holding Divi's Laboratories Limited

SBI Mutual Fund

Mutual Fund

3.90%

Government of Singapore

Foreign Investor

3.64%

LIC

Institution

2.53%

HDFC Mutual Fund

Mutual Fund

2.07%

Nippon India Mutual Fund

Mutual Fund

1.29%

Government Pension Fund Global (Norway)

Foreign Investor

1.23%

Latest move